Syon Capital’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Syon Capital's NVS Position: Q3 2026 in Review
Syon Capital increased its Novartis (NVS) stake by 4.6% in Q3 2026, buying an estimated $50.7K and bringing the position to 7,554 shares worth $1.08M. The position accounts for 0.04% of the portfolio, ranked #500.
Syon Capital first reported a position in NVS in Q3 2023 and has held it in 11 quarters since. The position peaked at $6.57M in Q3 2023. 1,561 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Syon Capital held 7,554 shares of Novartis worth $1.08M as of Q3 2026.
- Syon Capital bought 334 Novartis shares in Q3 2026, an estimated $50.7K.
- Novartis made up 0.04% of Syon Capital's portfolio in Q3 2026, its #500 holding.
- Syon Capital first reported a position in Novartis in Q3 2023 and has held it in 11 quarters since.
- Syon Capital's Novartis position peaked at $6.57M in Q3 2023.
- 1,561 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Syon Capital's 13F filing for Q3 2026, filed 16 Nov 2026.